Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Immunology"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
dewey-ones:"330 - Economics"
Showing
1
-
7
of
7
Search:
'"Immunology"'
,
query time: 0.03s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Comparative value of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) testing in combination versus individually for the diagnosis of undifferentiated patients wit...
by
Assasi, Nazila
Published 2015
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...C-Reactive Protein /
immunology
...
”
Read Now
2
Pharmacoeconomic review report: Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Immunologic
Factors / economics...
”
Read Now
3
Biologics versus immunomodulators or antibiotics for the management of fistulizing Crohn's disease : a review of comparative clinical effectiveness and cost-effectiveness
by
Young, Calvin
,
Campbell, Kaitryn
Published 2019
CADTH
Subjects:
“
...
Immunologic
Factors / therapeutic use...
”
Read Now
4
Biologics versus immunomodulators or antibiotics for the management of fistulizing Crohn's disease : a review of comparative clinical effectiveness and cost-effectiveness
by
Young, Calvin
,
Campbell, Kaitryn
Published 2019
CADTH
Subjects:
“
...
Immunologic
Factors / therapeutic use...
”
Read Now
5
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Immunologic
Factors / therapeutic use...
”
Read Now
6
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Immunologic
Factors / therapeutic use...
”
Read Now
7
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus-Hoffmann-La Roche Limited) : indication : management of adult patients with early primary progressive mult...
Published 2018
CADTH
Subjects:
“
...
Immunologic
Factors / economics...
”
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Classification: 330 - Economics
Year of Publication
From:
To:
Classification
330 - Economics
140 - Specific philosophical schools
5
610 - Medicine & health
5
Language
English
7
Collection
National Center for Biotechnology Information
7
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
3
Campbell, Kaitryn
2
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
2
Young, Calvin
2
Assasi, Nazila
1
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&lookfor=%22Immunology%22&type=Subject
Send by Email
×
Loading...